16:31:44 EDT Fri 09 May 2025
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save
Delphx Capital Markets Inc
Symbol DELX
Shares Issued 184,574,296
Close 2025-02-21 C$ 0.10
Market Cap C$ 18,457,430
Recent Sedar Documents

Delphx Capital closes $251,040 private placement

2025-02-21 17:42 ET - News Release

Mr. George Wentworth reports

DELPHX ANNOUNCES CLOSING OF NON-BROKERED UNIT PRIVATE PLACEMENT

Delphx Capital Markets Inc. has closed on a non-brokered private placement of 2,789,333 units at a subscription price of nine cents per unit for gross proceeds of $251,040. Each unit consists of one common share and one common share purchase warrant. Each warrant entitles the holder to purchase one common share at a price of 20 cents for a period of two years from the date of issuance.

The offering has been conditionally accepted by the TSX Venture Exchange, and completion of the offering is subject to the fulfilment or satisfaction of certain customary requirements and final acceptance by the TSX Venture Exchange. The securities issued pursuant to the offering will be subject to a hold period of four months plus one day from the date of issuance.

Delphx intends to use the net proceeds from the offering in connection with general corporate purposes.

About Delphx Capital Markets Inc.

Delphx is a technology and financial services company focused on developing and distributing the next generation of structured products. Through its special-purpose vehicle, Quantem LLC, the company enables fixed income dealers to offer new private placement securities that provide mitigation of spread and capital charge losses when downgrades occur, while allowing for attractive returns. The new Delphx securities will enable dealers and their qualified institutional investors (QIBs) accounts to competitively structure, sell and make markets in: collateralized put options (CPOs) that provide secured rating downgrade protection for underlying corporate bonds; and collateralized reference notes (CRNs) that enable investors to take on a capped rating downgrade exposure of an underlying security in exchange for attractive returns.

All CPOs and CRNs are fully collateralized and held in custody by BNY Mellon. CPOs and CRNs are proprietary products created and owned by Delphx Capital Markets.

© 2025 Canjex Publishing Ltd. All rights reserved.